InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Bruck Claudine, Director. Officer active across 2 companies, notably Navidea Biopharmaceuticals, INC.. In total, 4 reports have been recorded. Total volume traded: €9k. The latest transaction was filed on 11 October 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
€4,333181 shares@ €23.9403100.0% of flow
Common Stock
SEC:0001415889-21-004864·
Ideal exit: 8 Jul 2022 (T+270)
€4,333181 shares@ €23.94030.0046% mcap50.0% of flow
Common Stock
SEC:0001415889-21-004864:0·
Ideal exit: 8 Jul 2022 (T+270)
03,969 shares0
Common Stock
SEC:0001437749-21-016596·
03,969 shares0
Common Stock
SEC:0001437749-21-016596:0·
4 of 4 declarations
About Bruck Claudine
Claudine Bruck is a Director at NAVIDEA BIOPHARMACEUTICALS, INC. and Annovis Bio, Inc. She brings valuable expertise in the biopharmaceutical field, contributing to the strategy and governance of these companies. Her role as a director allows her to actively participate in strategic decision-making and oversee operations, thereby fostering growth and innovation.
